Luis Martı́nez-martı́nez

Luis Martı́nez-martı́nez's AcademicInfluence.com Rankings

Biology

#12923

World Rank

#16430

Historical Rank

Microbiology

#784

World Rank

#860

Historical Rank

Neuroscience

#2211

World Rank

#2272

Historical Rank

biology Degrees

Download Badge

Biology

Luis Martı́nez-martı́nez's Degrees

PhD Microbiology University of Barcelona
Masters Biotechnology University of Barcelona
Bachelors Biology University of Barcelona

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Luis Martı́nez-martı́nez Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Luis Martı́nez-martı́nez's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Quinolone resistance from a transferable plasmid (1998) (1126)
Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients (2004) (508)
EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance (2012) (422)
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. (2010) (390)
Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence (2009) (306)
Emergence of Plasmid-Mediated Quinolone Resistance in Escherichia coli in Europe (2005) (300)
Roles of β-Lactamases and Porins in Activities of Carbapenems and Cephalosporins against Klebsiella pneumoniae (1999) (261)
In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins (1996) (240)
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. (2008) (238)
Plasmid-mediated quinolone resistance: an update (2011) (212)
Nationwide Study of Escherichia coli and Klebsiella pneumoniae Producing Extended-Spectrum β-Lactamases in Spain (2005) (197)
Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans (1993) (194)
Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones (2012) (192)
Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. (2003) (192)
Porin expression in clinical isolates of Klebsiella pneumoniae. (1999) (190)
Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study (2011) (186)
Role of Klebsiella pneumoniae OmpK35 Porin in Antimicrobial Resistance (2003) (170)
Contribution of Efflux Pumps, Porins, and β-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii (2013) (160)
Clinical Features and Epidemiology of Acinetobacter baumannii Colonization and Infection in Spanish Hospitals (2004) (149)
Plasmid-mediated quinolone resistance: Two decades on. (2016) (134)
Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections. (2015) (134)
National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. (2011) (133)
Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post Hoc analysis of a prospective cohort. (2013) (133)
Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. (2007) (130)
Identification and Characterization of a New Porin Gene of Klebsiella pneumoniae: Its Role in β-Lactam Antibiotic Resistance (1999) (130)
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. (2005) (128)
Prospective Multicenter Study of the Impact of Carbapenem Resistance on Mortality in Pseudomonas aeruginosa Bloodstream Infections (2011) (128)
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae (2016) (127)
Extended-spectrum β-lactamases and the permeability barrier (2008) (126)
Prospective Multicenter Study of Carbapenemase-Producing Enterobacteriaceae from 83 Hospitals in Spain Reveals High In Vitro Susceptibility to Colistin and Meropenem (2015) (124)
Interaction of plasmid and host quinolone resistance. (2003) (122)
Emergence of imipenem resistance in clinical Escherichia coli during therapy. (2008) (117)
qnr, aac(6')-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location. (2012) (117)
Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants (2008) (114)
Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. (2000) (114)
Detection of the Pandemic O25-ST131 Human Virulent Escherichia coli CTX-M-15-Producing Clone Harboring the qnrB2 and aac(6′)-Ib-cr Genes in a Dog (2008) (113)
Alterations of OprD in Carbapenem-Intermediate and -Susceptible Strains of Pseudomonas aeruginosa Isolated from Patients with Bacteremia in a Spanish Multicenter Study (2012) (111)
Outer Membrane Profiles of Clonally Related Klebsiella pneumoniae Isolates from Clinical Samples and Activities of Cephalosporins and Carbapenems (1998) (109)
Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. (2012) (106)
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain (2017) (106)
Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain (2013) (105)
Evaluation of the VITEK 2 System for the Identification and Susceptibility Testing of Three Species of Nonfermenting Gram-Negative Rods Frequently Isolated from Clinical Samples (2001) (104)
Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum-β-lactamase-producing Klebsiella pneumoniae. (2013) (102)
Use of Positive Blood Cultures for Direct Identification and Susceptibility Testing with the Vitek 2 System (2004) (100)
Development of Resistance during Antimicrobial Therapy Caused by Insertion Sequence Interruption of Porin Genes (1999) (100)
Diversity of Escherichia coli Strains Producing Extended-Spectrum β-Lactamases in Spain: Second Nationwide Study (2010) (99)
Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach. (2009) (97)
Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones (2013) (97)
Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase. (2003) (92)
Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. (2018) (90)
Zinc Eluted from Siliconized Latex Urinary Catheters Decreases OprD Expression, Causing Carbapenem Resistance in Pseudomonas aeruginosa (2003) (85)
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases (2005) (83)
Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing (2016) (82)
Mutant Prevention Concentrations of Fluoroquinolones for Enterobacteriaceae Expressing the Plasmid-Carried Quinolone Resistance Determinant qnrA1 (2007) (81)
Activities of Imipenem and Cephalosporins against Clonally Related Strains of Escherichia coli Hyperproducing Chromosomal β-Lactamase and Showing Altered Porin Profiles (2000) (78)
Energy-Dependent Accumulation of Norfloxacin and Porin Expression in Clinical Isolates of Klebsiella pneumoniae and Relationship to Extended-Spectrum β-Lactamase Production (2002) (75)
Four Main Virotypes among Extended-Spectrum-β-Lactamase-Producing Isolates of Escherichia coli O25b:H4-B2-ST131: Bacterial, Epidemiological, and Clinical Characteristics (2013) (75)
Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae: Validation of Scores and Proposal for Management (2018) (73)
Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort. (2014) (72)
Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli. (2014) (72)
Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology. (2019) (71)
Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids. (2006) (71)
High Concentrations of Manganese in Mueller-Hinton Agar Increase MICs of Tigecycline Determined by Etest (2009) (71)
Role of association of OmpK35 and OmpK36 alteration and blaESBL and/or blaAmpC genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae. (2018) (69)
Phenotypic characteristics of 31 strains of Corynebacterium striatum isolated from clinical samples (1995) (66)
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain. (2016) (65)
Detection of Plasmid-Mediated Quinolone Resistance Genes in Clinical Isolates of Enterobacter spp. in Spain (2009) (63)
Carbapenemases in Enterobacteriaceae: types and molecular epidemiology. (2014) (62)
Extended-spectrum beta-lactamases and the permeability barrier. (2008) (62)
Occurrence of Corynebacterium striatum as an emerging antibiotic-resistant nosocomial pathogen in a Tunisian hospital (2017) (60)
Relationship between Mutations in the gyrA Gene and Quinolone Resistance in Clinical Isolates of Corynebacterium striatum and Corynebacterium amycolatum (2005) (59)
Accuracy of different diagnostic tests for early, delayed and late prosthetic joint infection (2017) (57)
Comparison of E-test with broth microdilution and disk diffusion for susceptibility testing of coryneform bacteria (1995) (57)
Relationship between β-lactamase production , outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii (2003) (55)
Non-molecular detection of carbapenemases in Enterobacteriaceae clinical isolates. (2017) (55)
Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps. (2015) (54)
Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131. (2014) (54)
Plasmid-mediated quinolone resistance (2008) (53)
Carbapenem-resistant Klebsiella pneumoniae isolates from Egypt containing blaNDM-1 on IncR plasmids and its association with rmtF. (2016) (52)
[Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)]. (2003) (52)
Biofilm formation by multidrug resistant Enterobacteriaceae strains isolated from solid organ transplant recipients (2019) (51)
[Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)]. (2009) (51)
Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study. (2010) (50)
Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coli (2012) (49)
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum &bgr;-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort (2017) (49)
Clinical significance of Corynebacterium striatum isolated from human samples. (1997) (48)
Type 1 Integrons in Epidemiologically Unrelated Acinetobacter baumannii Isolates Collected at Spanish Hospitals (2004) (48)
Activity of eight antibacterial agents on Staphylococcus epidermidis attached to Teflon catheters. (1994) (47)
Mutational analysis of quinolone resistance in the plasmid-encoded pentapeptide repeat proteins QnrA, QnrB and QnrS. (2009) (47)
In Vitro Adherence of Enterococcus faecalis and Enterococcus faecium to Urinary Catheters (2000) (47)
First identification of NDM-5 associated with OXA-181 in Escherichia coli from Egypt (2016) (45)
Kinetics of adherence of mucoid and non-mucoid Pseudomonas aeruginosa to plastic catheters. (1991) (45)
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study. (2016) (45)
Analysis of Genes Encoding Penicillin-Binding Proteins in Clinical Isolates of Acinetobacter baumannii (2011) (44)
Energy-Dependent Accumulation of Fluoroquinolones in Quinolone-Resistant Klebsiella pneumoniaeStrains (1998) (44)
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli. (1999) (44)
Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant β-Lactam Resistance Mechanisms (2016) (43)
26Postoperative diagnosis and outcome in patients with revision arthroplasty for aseptic loosening (2015) (43)
Antimicrobial susceptibility pattern of Corynebacterium striatum (1996) (43)
How to measure and monitor antimicrobial consumption and resistance. (2013) (41)
Identification of Clinically Relevant Corynebacterium spp., Arcanobacterium haemolyticum, and Rhodococcus equi by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry (2012) (41)
In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens (2020) (40)
Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe. (2015) (39)
CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain. (2016) (39)
Biofilm Formation and Quorum-Sensing-Molecule Production by Clinical Isolates of Serratia liquefaciens (2015) (38)
Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants (2019) (38)
High-level quinolone resistance is associated with the overexpression of smeVWX in Stenotrophomonas maltophilia clinical isolates. (2015) (38)
In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii. (1996) (37)
Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1. (2008) (37)
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases. (2005) (35)
Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering. (2015) (34)
Overproduction of Outer Membrane Protein A by Acinetobacter baumannii as a Risk Factor for Nosocomial Pneumonia, Bacteremia, and Mortality Rate Increase (2017) (34)
Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms (2016) (34)
Klebsiella pneumoniae Strains Producing Extended-Spectrum β-Lactamases in Spain: Microbiological and Clinical Features (2010) (33)
Multicenter Study Evaluating the Role of Enterococci in Secondary Bacterial Peritonitis (2009) (33)
Characterization of the first CTX-M-14-producing Salmonella enterica serotype Enteritidis isolate. (2004) (33)
Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system. (2014) (33)
Effect of the efflux pump QepA2 combined with chromosomally mediated mechanisms on quinolone resistance and bacterial fitness in Escherichia coli. (2015) (33)
Effect of three plastic catheters on survival and growth of Pseudomonas aeruginosa. (1990) (33)
Resistance of Pseudomonas aeruginosa to Imipenem Induced by Eluates from Siliconized Latex Urinary Catheters Is Related to Outer Membrane Protein Alterations (1999) (33)
[In vitro activity of 18 antimicrobial agents against clinical isolates of Acinetobacter spp.: multicenter national study GEIH-REIPI-Ab 2010]. (2013) (32)
Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain. (2015) (32)
Molecular characterization of multiresistant Escherichia coli producing or not extended-spectrum β-lactamases (2013) (32)
In vitro adherence of Enterococcus faecalis and Enterococcus faecium to plastic biomaterials. (1999) (32)
Epidemiologic and Clinical Impact of Acinetobacter baumannii Colonization and Infection (2014) (32)
Evaluation of the carbapenem inactivation method (CIM) for detecting carbapenemase activity in enterobacteria. (2017) (31)
Post-operative mediastinitis, pleuritis and pericarditis due to Mycoplasma hominis and Ureaplasma urealyticum with a fatal outcome. (2008) (31)
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-&bgr;-lactamase-producing Enterobacteriaceae (2017) (30)
Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegansPseudomonas aeruginosa Infection Model (2017) (30)
An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia. (2018) (30)
Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime. (2011) (30)
Human neutrophils phagocytose and kill Acinetobacter baumannii and A. pittii (2017) (28)
In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase. (2006) (28)
Identification of Atypical Rhodococcus-Like Clinical Isolates as Dietzia spp. by 16S rRNA Gene Sequencing (2010) (28)
Adherence to recommendations by infectious disease consultants and its influence on outcomes of intravenous antibiotic-treated hospitalized patients (2012) (27)
Isolation of VIM-2-Producing Pseudomonas monteilii Clinical Strains Disseminated in a Tertiary Hospital in Northern Spain (2014) (27)
Activities of Gemifloxacin and Five Other Antimicrobial Agents against Listeria monocytogenes and Coryneform Bacteria Isolated from Clinical Samples (2001) (27)
Lower ototoxicity and absence of hidden hearing loss point to gentamicin C1a and apramycin as promising antibiotics for clinical use (2019) (26)
Comparison of broth microdilution and E-test for susceptibility testing of Neisseria meningitidis (1996) (25)
Quality Control for β-Lactam Susceptibility Testing with a Well-Defined Collection of Enterobacteriaceae and Pseudomonas aeruginosa Strains in Spain (2003) (25)
Acinetobacter baumannii and A. pittii clinical isolates lack adherence and cytotoxicity to lung epithelial cells in vitro. (2016) (25)
[Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000)]. (2004) (25)
Combined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant Acinetobacter baumannii (2019) (24)
In vitro Activity of Azithromycin in Combination with Amikacin, Ceftazidime, Ciprofloxacin or Imipenem against Clinical Isolates of Acinetobacter baumannii (2003) (24)
[Prevalence of the tetA and tetB genes as mechanisms of resistance to tetracycline and minocycline in Acinetobacter baumannii clinical isolates]. (2006) (24)
Characterisation of integrons containing the plasmid-mediated quinolone resistance gene qnrA1 in Klebsiella pneumoniae. (2007) (24)
Energy-Dependent Accumulation of Fluoroquinolones in Quinolone-Resistant Klebsiella pneumoniae Strains (1998) (23)
In-vitro activity of levofloxacin, ofloxacin and D-ofloxacin against coryneform bacteria and Listeria monocytogenes. (1999) (23)
In Vitro Activities of Ketolide HMR 3647, Macrolides, and Clindamycin against Coryneform Bacteria (1998) (23)
Microbiological and clinical aspects of respiratory infections associated with Bordetella bronchiseptica. (2015) (23)
Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: report of a case and review of the literature. (2019) (23)
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteremia - retrospective multicenter study. (2019) (23)
Activity of nine antimicrobial agents against clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and deficient or not in porins. (2000) (23)
Evolution of the Quorum network and the mobilome (plasmids and bacteriophages) in clinical strains of Acinetobacter baumannii during a decade (2018) (23)
Trends in the susceptibilities of Proteus mirabilis isolates to quinolones. (2000) (23)
Comment on: Redefining extended-spectrum beta-lactamases: balancing science and clinical need. (2009) (22)
Effect of a siliconized latex urinary catheter on bacterial adherence and human neutrophil activity. (1991) (22)
Antimicrobial Susceptibility and Mechanisms of Resistance to Quinolones and β-Lactams in Acinetobacter Genospecies 3 (2004) (22)
Comparative in vitro activities of new quinolones against coryneform bacteria (1994) (22)
Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii. (2012) (22)
Genetic Variability among ampC Genes from Acinetobacter Genomic Species 3 (2008) (22)
Response to Bile Salts in Clinical Strains of Acinetobacter baumannii Lacking the AdeABC Efflux Pump: Virulence Associated with Quorum Sensing (2017) (22)
Characterization of Carbapenemase-Producing Klebsiella oxytoca in Spain, 2016–2017 (2019) (22)
Effect of siliconized latex urinary catheters on the activity of carbapenems against Pseudomonas aeruginosa strains with defined mutations in ampC, oprD, and genes coding for efflux systems. (2003) (21)
Bloodstream infection caused by Acinetobacter junii in a patient with acute lymphoblastic leukaemia after allogenic haematopoietic cell transplantation. (2011) (21)
Clinical significance of newly recognized coryneform bacteria (1998) (21)
[Epidemiology, clinical features and prognosis of infections due to Stenotrophomonas maltophilia]. (2006) (20)
Mutational and acquired carbapenem resistance mechanisms in multidrug resistant Pseudomonas aeruginosa clinical isolates from Recife, Brazil (2015) (20)
Chemiluminescence of human polymorphonuclear leucocytes after stimulation with whole cells and cell-wall components of Staphylococcus epidermidis. (1993) (20)
Genotypic versus Phenotypic Characterization, with Respect to β-Lactam Susceptibility, of Haemophilus influenzae Isolates Exhibiting Decreased Susceptibility to β-Lactam Resistance Markers (2008) (20)
Fatal pulmonary infection caused by Corynebacterium striatum. (1994) (20)
[Antimicrobial mechanisms of action]. (2009) (20)
Changes in Ciprofloxacin Resistance Levels in Enterobacter aerogenes Isolates Associated with Variable Expression of the aac(6′)-Ib-cr Gene (2011) (19)
Ceftazidime-avibactam in the Treatment of Infections Caused by KPC-producing K. pneumoniae: factors associated with clinical efficacy in a single-center cohort. (2020) (19)
[Resistance to quinolones and beta-lactams in Salmonella enterica due to mutations in topoisomerase-encoding genes, altered cell permeability and expression of an active efflux system]. (2004) (19)
Degenerate primer MOB typing of multiresistant clinical isolates of E. coli uncovers new plasmid backbones. (2015) (19)
Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain. (2006) (19)
Isolation of Mycoplasma hominis in critically ill patients with pulmonary infections: clinical and microbiological analysis in an intensive care unit (2006) (18)
MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae (2017) (18)
Inhibitor-Resistant TEM- and OXA-1-Producing Escherichia coli Isolates Resistant to Amoxicillin-Clavulanate Are More Clonal and Possess Lower Virulence Gene Content than Susceptible Clinical Isolates (2014) (18)
Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients. (2015) (18)
Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project. (2016) (17)
Mobile Genetic Elements Related to the Diffusion of Plasmid-Mediated AmpC β-Lactamases or Carbapenemases from Enterobacteriaceae: Findings from a Multicenter Study in Spain (2015) (17)
Susceptibility to Aminoglycosides and Distribution of aph and aac(3)-XI Genes among Corynebacterium striatum Clinical Isolates (2016) (17)
Acquisition of carbapenem resistance in multiresistant Klebsiella pneumoniae strains harbouring blaCTX-M-15, qnrS1 and aac(6')-Ib-cr genes. (2012) (17)
Genomic analysis of 40 prophages located in the genomes of 16 carbapenemase-producing clinical strains of Klebsiella pneumoniae (2020) (17)
[Multiresistant Gram-negative bacterial infections: Enterobacteria, Pseudomonas aeruginosa, Acinetobacter baumannii and other non-fermenting Gram-negative bacilli]. (2013) (16)
Outbreak of Invasive Group A Streptococcal Disease Among Children Attending a Day-Care Center (2008) (16)
Discrepancies in fluoroquinolone clinical categories between the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI for Escherichia coli harbouring qnr genes and mutations in gyrA and parC. (2011) (16)
[The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: current situation]. (2010) (16)
Acinetobacter baumannii in critically ill patients: Molecular epidemiology, clinical features and predictors of mortality. (2016) (16)
Sternal wound infection caused by Gordonia bronchialis: identification by MALDI-TOF MS (2016) (15)
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes (2008) (15)
Severe Pneumonia and Human Bocavirus in Adult (2006) (15)
Efficacy of Cefepime and Imipenem in Experimental Murine Pneumonia Caused by Porin-Deficient Klebsiella pneumoniae Producing CMY-2 β-Lactamase (2005) (15)
Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes. (2015) (14)
False extended-spectrum beta-lactamase detection in Acinetobacter spp. due to intrinsic susceptibility to clavulanic acid. (2007) (14)
Comparison of the Vitek MS and Bruker Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Systems for Identification of Rhodococcus equi and Dietzia spp (2017) (14)
Effect of ciprofloxacin and ofloxacin on human polymorphonuclear leukocyte activity against staphylococci. (1989) (14)
OXA-207, a Novel OXA-24 Variant with Reduced Catalytic Efficiency against Carbapenems in Acinetobacter pittii from Spain (2014) (14)
Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey. (2019) (14)
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase‐producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia (2019) (14)
Evaluation of differential gene expression in susceptible and resistant clinical isolates of Klebsiella pneumoniae by DNA microarray analysis. (2006) (14)
Detection of Resistance to Beta-Lactamase Inhibitors in Strains with CTX-M Beta-Lactamases: a Multicenter External Proficiency Study Using a Well-Defined Collection of Escherichia coli Strains (2013) (14)
[Acinetobacter baumannii bacteremia: clinical and prognostic features]. (2003) (14)
Epidemiological and Clinical Complexity of Amoxicillin-Clavulanate-Resistant Escherichia coli (2013) (13)
In-vitro susceptibilities of multiresistant strains of Acinetobacter baumannii to eight quinolones. (1997) (13)
Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance. (2017) (13)
Epidemiological and clinical features associated with colonisation/infection by Acinetobacter baumannii with phenotypic heterogeneous resistance to carbapenems. (2012) (13)
Evaluation of antimicrobial susceptibility of bacteria containing the qnr gene and FOX-5 beta-lactamase by four automated systems. (2005) (13)
[Molecular characterization of Pseudomonas aeruginosa isolates in Cantabria, Spain, producing VIM-2 metallo-beta-lactamase]. (2010) (13)
Overproduction of outer membrane protein A (OmpA) by Acinetobacter baumannii is a risk factor for nosocomial pneumonia, bacteremia and mortality increase. (2017) (12)
Prevalence of quinolone resistance mechanisms in Enterobacteriaceae producing acquired AmpC β-lactamases and/or carbapenemases in Spain. (2017) (12)
Rates of faecal colonization by carbapenemase-producing Enterobacteriaceae among patients admitted to ICUs in Spain. (2015) (12)
Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients (2015) (12)
Antimicrobial susceptibility of microorganisms that cause urinary tract infections in pediatric patients. (2017) (12)
Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000–2015 (2021) (12)
Prevalence of Aminoglycoside-Modifying Enzymes in Escherichia coli and Klebsiella pneumoniae Producing Extended Spectrum β-Lactamases Collected in Two Multicenter Studies in Spain. (2018) (11)
Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by A. baumannii (2018) (11)
Clinical Features of Infections and Colonization by Acinetobacter Genospecies 3 (2010) (11)
Clinical characteristics and outcome of bacteremia caused by Enterobacter cloacae and Klebsiella aerogenes: more similarities than differences. (2021) (10)
Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: the impact of inappropriate empirical treatment. (2019) (10)
Comparison of different culture media and growth conditions for recognition of Arcanobacterium haemolyticum. (2008) (10)
Biomarker Tools to Design Clinical Vaccines Determined from a Study of Annual Listeriosis Incidence in Northern Spain (2016) (9)
A prospective, multicenter, and non-interventional case control study about the risk factors associated to acquisition and mortality of Enterobacter species bacteremia. (2020) (9)
Phenotypic and molecular characterization of Arcanobacterium haemolyticum isolated from clinical samples. (2012) (9)
Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain). (2007) (9)
Interaction of macrophages with a cytotoxic Serratia liquefaciens human isolate. (2013) (9)
Colonization by high-level aminoglycoside-resistant enterococci in intensive care unit patients: epidemiology and clinical relevance. (2005) (9)
Hyperproduction of AmpC beta-lactamase in a clinical isolate of Escherichia coli associated with a 30 bp deletion in the attenuator region of ampC. (2005) (9)
Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase. (2005) (9)
Impact of KPC Production and High-Level Meropenem Resistance on All-Cause Mortality of Ventilator-Associated Pneumonia in Association with Klebsiella pneumoniae (2020) (9)
Activity of eight fluoroquinolones against enterococci. (1997) (9)
External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteremia cohort: The prognostic significance of colistin resistance. (2019) (9)
Oral decontamination with colistin plus neomycin in solid organ transplant recipients colonized by multidrug-resistant Enterobacterales: a multicenter, randomized, controlled, open-label, parallel-group clinical trial. (2020) (9)
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection (2022) (8)
Erratum for del Barrio-Tofiño et al., “Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain” (2017) (8)
Resistance of Streptococcus pneumoniae to penicillin, erythromycin and third-generation cephalosporins in Seville, Southern Spain. (1997) (8)
Challenges to accurate susceptibility testing and interpretation of quinolone resistance in Enterobacteriaceae: results of a Spanish multicentre study. (2015) (8)
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study. (2017) (8)
[Development of resistances to antibiotic drugs: causes, consequences and importance to the public health system]. (2010) (8)
Recurrent respiratory infection caused by Bordetella bronchiseptica in an immunocompetent infant. (2012) (8)
High Prevalence of Extensively Drug-resistant Acinetobacter baumannii at a Children Hospital in Bolivia (2018) (8)
Aminoglycoside resistance determinants in multiresistant Escherichia coli and Klebsiella pneumoniae clinical isolates from Turkish and Syrian patients. (2019) (8)
[Effect of subinhibitory concentrations of beta-lactams on the production of slime, surface hydrophobicity and adhesion of Staphylococcus epidermidis]. (1991) (7)
Susceptibility to antimicrobial agents ofPseudomonas aeruginosa attached to siliconized latex urinary catheters (1993) (7)
Antimicrobial Susceptibility and Characterization of Resistance Mechanisms of Corynebacterium urealyticum Clinical Isolates (2020) (7)
Meropenem heteroresistance in clinical isolates of OXA-48-producing Klebsiella pneumoniae. (2019) (7)
Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host (2022) (7)
Phenotypic and Genomic Comparison of Klebsiella pneumoniae Lytic Phages: vB_KpnM-VAC66 and vB_KpnM-VAC13 (2021) (7)
Molecular characterization of multidrug resistant Enterobacterales strains isolated from liver and kidney transplant recipients in Spain (2021) (7)
From CLSI to EUCAST, a necessary step in Spanish laboratories. (2018) (7)
Tsukamurella pulmonis Bloodstream Infection Identified by secA1 Gene Sequencing (2014) (7)
Genomic Evolution of Two Acinetobacter baumannii Clinical Strains from ST-2 Clones Isolated in 2000 and 2010 (ST-2_clon_2000 and ST-2_clon_2010) (2016) (6)
Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems. (2020) (6)
Comparison of susceptibility testing methods for determining the activity of colistin against Gram‐negative bacilli of clinical origin (2019) (6)
Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections. (2020) (6)
Amino Acid Substitutions and Differential Gene Expression of Outer Membrane Proteins in Adherent-Invasive Escherichia coli (2019) (6)
Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis. (2017) (6)
Efficacy of β‐lactam/β‐lactamase inhibitors to treat extended‐spectrum beta‐lactamase‐producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT‐SOT Project) (2020) (6)
Risk Factors for Multidrug-Resistant Gram-Negative Bacteria Carriage upon Admission to the Intensive Care Unit (2022) (6)
Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem Resistant Gram-Negative Bacilli: An Interrupted Time-Series Analysis (2021) (6)
Evaluation of Three Automated Systems for Susceptibility Testing of Enterobacteria Containing qnrB, qnrS, and/or aac(6′)-Ib-cr (2008) (6)
Detection of enterovirulent Escherichia coli associated with diarrhoea in Seville, southern Spain, with non-radioactive DNA probes. (1993) (6)
Comparison of clinical categories for Escherichia coli harboring specific qnr and chromosomal-mediated fluoroquinolone resistance determinants according to CLSI and EUCAST. (2016) (6)
Characterization of OXA-48-producing Klebsiella oxytoca isolates from a hospital outbreak in Tunisia. (2021) (6)
Comparison between Vitek MS, Bruker Biotyper, Vitek2, and API20E for differentiation of species of the genus Raoultella (2019) (5)
Carbapenemases: The never-ending story. (2019) (5)
Enhanced Antibacterial Activity of Repurposed Mitomycin C and Imipenem in Combination with the Lytic Phage vB_KpnM-VAC13 against Clinical Isolates of Klebsiella pneumoniae (2021) (5)
In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime-avibactam (2022) (5)
[Bacteremia associated with mycotic aneurysm of the transversal aortic arch and myocarditis caused by Salmonella enteritidis]. (1989) (5)
Comparison of three methods of determining the in-vitro susceptibilities of Acinetobacter baumannii isolates to imipenem. (1997) (5)
Detection of phylogenetic group B1 Escherichia coli by multiplex PCR: description of a new amplification pattern. (2011) (5)
[Recommendations for selecting antimicrobial agents for in vitro susceptibility studies using automatic and semiautomatic systems]. (2007) (5)
[Ciprofloxacin resistance in gram negative bacilli. Epidemiologic aspects]. (1993) (5)
Evaluation of the Vitek-MS™ system in the identification of Candida isolates from bloodstream infections. (2018) (5)
Whole genome sequencing reveals misidentification of a multidrug-resistant urine clinical isolate as Corynebacterium urealyticum. (2020) (5)
Effect of preincubation of Pseudomonas aeruginosa in subinhibitory concentrations of amikacin, ceftazidime and ciprofloxacin on adherence to plastic catheters. (1991) (5)
Corynebacterium jeikeium osteomyelitis successfully treated with teicoplanin. (1997) (4)
Susceptibility to amoxycillin-clavulanate among clinical isolates of Escherichia coli resistant to cefoxitin. (2006) (4)
Adherence to Human Colon Cells by Multidrug Resistant Enterobacterales Strains Isolated From Solid Organ Transplant Recipients With a Focus on Citrobacter freundii (2020) (4)
Antimicrobial Resistance Profiles of Adherent Invasive Escherichia coli Show Increased Resistance to β-Lactams (2020) (4)
High-risk clones and novel sequence type ST4497 of Klebsiella pneumoniae clinical isolates producing different alleles of NDM-type and other carbapenemases from a single tertiary care center in Egypt. (2020) (4)
Phenotypic detection of clinical isolates of Haemophilus influenzae with altered penicillin-binding protein 3 (2018) (4)
Association between rectal colonization by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae and mortality: a prospective, observational study. (2021) (4)
Pneumococcal meningitis in Cantabria (Spain) in the pneumococcal conjugate vaccine era (2001-2015). (2017) (4)
[The Spanish antibiogram committee (COESANT), in step with EUCAST]. (2013) (4)
Metallacarborane Assemblies as Effective Antimicrobial Agents, Including a Highly Potent Anti-MRSA Agent (2020) (4)
Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-β-naphthylamide (PaβN): co-resistance to antimicrobials. (2022) (4)
Activity of daptomycin and three comparator agents against non-diphtheriae Corynebacterium isolates of clinical interest. (2012) (4)
Draft Genome Sequence of the Quorum-Sensing and Biofilm-Producing Pseudomonas aeruginosa Strain Pae221, Belonging to the Epidemic High-Risk Clone Sequence Type 274 (2015) (4)
Erratum to: Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain (2012) (4)
Cephalothin is not a reliable surrogate marker for oral cephalosporins in susceptibility testing of Enterobacteriaceae causing urinary tract infection. (2016) (4)
Whole-Genome Sequence of Serratia liquefaciens HUMV-21, a Cytotoxic, Quorum-Sensing, and Biofilm-Producing Clinical Isolate (2015) (4)
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study (2022) (3)
Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin. (2008) (3)
Evaluation of the WIDER I system for antimicrobial susceptibility testing of clinical isolates of Haemophilus influenzae and Streptococcus pneumoniae. (2003) (3)
Activities of ABT-773 against Listeria monocytogenes and Coryneform Bacteria of Clinical Interest (2003) (3)
Fundamentals and implementation of Microbiological Diagnostic Stewardship Programs. (2020) (3)
[Antimicrobial activity in Staphylococcus epidermidis biofilms on polyvinyl chloride catheters]. (1995) (3)
Multi-center and multi-method evaluation of in vitro activities of ceftaroline against S. aureus. (2016) (3)
Evolution of the antimicrobial resistance rates in clinical isolates of Pseudomonas aeruginosa causing invasive infections in the south of Spain. (2019) (3)
Genomic surveillance of enterovirus associated with aseptic meningitis cases in southern Spain, 2015–2018 (2021) (3)
Proof‑of‑concept study to quantify changes in intestinal loads of KPC-producing Klebsiella pneumoniae in colonized patients following selective digestive decontamination with oral gentamicin. (2022) (3)
Whole-Genome Sequence of Hafnia alvei HUMV-5920, a Human Isolate (2016) (3)
Detection of Hypermutable Escherichia coli Strains in a Collection of Clinical Isolates by the Fosfomycin-Rifampin Disk Method (2006) (3)
[Outbreak of streptococcal toxic shock syndrome in a day care center in Cantabria, Spain, 2006]. (2008) (2)
Resistance mechanisms in Gram-negative bacteria. (2022) (2)
Association between Timing of Colonization and Risk of Developing Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infection in Hospitalized Patients (2022) (2)
Justification for 24/7 clinical microbiology services (2021) (2)
Integrating In Vitro and In Silico Analysis of a Cationic Antimicrobial Peptide Interaction with Model Membranes of Colistin-Resistant Pseudomonas aeruginosa Strains (2022) (2)
[Antimicrobial susceptibility cumulative reports]. (2016) (2)
Production of HlyA and ClyA haemolysins among quinolone-resistant Escherichia coli isolated from clinical samples (2013) (2)
Phenotypic detection of clinical isolates of Haemophilus influenzae with altered penicillin-binding protein 3 (2018) (2)
[Epidemiological surveillance cultures in antimicrobial-resistant bacteria causing nosocomial infection]. (2008) (2)
Multicenter Performance Evaluation of MALDI-TOF MS for Rapid Detection of Carbapenemase Activity in Enterobacterales: The Future of Networking Data Analysis With Online Software (2022) (2)
Bacteremia caused by Leuconostoc Spp (1992) (2)
Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study). (2022) (2)
CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3 (2022) (2)
[Correlation between MALDI-TOF Vitek-MSTM system and conventional identification methods of gastrointestinal infection causing bacteria]. (2016) (2)
[Relationships between resistance to cefoxitin, ciprofloxacin and amoxicillin-clavulanic acid in Escherichia coli clinical isolates]. (2005) (2)
Activity of Cefotaxime and Amikacin against 14,272 Gram-Negative Bacteria from Clinical Samples in the Period 1980 to 1985 (2012) (1)
Comparative study of in vitro activity of tedizolid and linezolid against Mycobacterium avium complex. (2022) (1)
[Decreasing susceptibility to vancomycin in isogenic Staphylococcus aureus strains isolated from a single patient]. (2001) (1)
[Usefulness of the disk diffusion method for evaluating the sensitivity of Neisseria meningitidis to penicillin and cefotaxime]. (1997) (1)
Escherichia coli resistant to quinolones in a neonatal unit. (2011) (1)
WU and KI Polyomavirus Prevalence in Invasive Respiratory Samples From Transplant Recipients in Cantabria, Spain (2015) (1)
Evaluation of CrystalTM Rapid Stool/Enteric ID System for Identification of Aerobic Gram-negative Bacilli. (1995) (1)
In vitro and in vivo efficacy of the combination of colistin and endolysins against clinical strains of Multi-Drug Resistant (MDR) pathogens (2019) (1)
[Repeating the Platelia™ Aspergillus test in samples positive for serum galactomannan: Is it necessary?]. (2015) (1)
P1722 Accuracy of the VITEK 2 system to identify coagulase-negative staphylococci (2007) (1)
amoxicillin-clavulanate in Escherichia coli: A Spanish (2012) (1)
Evolution of the antimicrobial resistance rates in clinical isolates of Pseudomonas aeruginosa causing invasive infections in the south of Spain (2020) (1)
Urinary tract infection caused by quinolone-resistant Campylobacter coli. (1994) (1)
[Bacterial death and heteroresistance to antimicrobial agents]. (2008) (1)
Hidden dissemination of carbapenem-susceptible OXA-48-producing Proteus mirabilis. (2022) (1)
Evaluation of Vitek-MS™ and Microflex LT™ commercial systems for identification of Acinetobacter calcoaceticus-baumannii complex. (2020) (1)
Randomised, double-blind, placebo-controlled, phase 2, superiority trial to demonstrate the effectiveness of faecal microbiota transplantation for selective intestinal decolonisation of patients colonised by carbapenemase-producing Klebsiella pneumoniae (KAPEDIS) (2022) (1)
Author Correction: Biofilm formation by multidrug resistant Enterobacteriaceae strains isolated from solid organ transplant recipients (2020) (1)
Propensity Score and Desirability of Outcome Ranking Analysis of Ertapenem for Treatment of Nonsevere Bacteremic Urinary Tract Infections Due to Extended-Spectrum-Beta-Lactamase-Producing Enterobacterales in Kidney Transplant Recipients (2021) (1)
Deciphering the resistome of the widespread P. aeruginosa ST175 international high-risk clone through whole genome sequencing (2018) (1)
[Adhesion capacity and surface properties of Staphylococcus epidermidis and Staphylococcus saprophyticus]. (1989) (1)
Fundamentals and implementation of Microbiological Diagnostic Stewardship Programs (2021) (1)
P681 Emergence of worldwide epidemic clones of vancomycin-resistant Enterococcus faecium in a Northern Spain hospital (2007) (1)
[Evaluation of 2 methods for studying slime production by coagulase-negative Staphylococcus strains]. (1989) (1)
Fatal pneumonia in a newborn caused by Oerskovia xanthineolytica (2010) (1)
Combined Use of the Ab105-2фΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multiresistant Acinetobacter Baumannii (2019) (1)
Variability of ompC and ompF porin genes in multi-resistant clinical isolates of E. coli (2011) (1)
[Effect of delayed incubation of blood culture bottles in detecting bacterial growth with the Bact/Alert 3D system]. (2001) (1)
Genomic Diversity of Mycobacterium tuberculosis Complex Strains in Cantabria (Spain), a Moderate TB Incidence Setting (2016) (1)
Antimicrobial susceptibility of microorganisms that cause urinary tract infections in pediatric patients (2018) (0)
, and Virulence Contributes to Antimicrobial Resistance AcrAB Efflux Pump Klebsiella pneumoniae (2009) (0)
pneumoniae Klebsiella Cephalosporins against Activities of Carbapenems and -Lactamases and Porins in β Roles of (2014) (0)
In-vitro activity of levoﬂoxacin, oﬂoxacin and D -oﬂoxacin against coryneform bacteria and Listeria monocytogenes (1999) (0)
Comparison between Vitek MS, Bruker Biotyper, Vitek2, and API20E for differentiation of species of the genus Raoultella (2019) (0)
Evolution of the Quorum network and the mobilome (plasmids and bacteriophages) in clinical strains of Acinetobacter baumannii during a decade (2018) (0)
Phenotypic and Molecular Characterization of an Enterobacter ludwigii Clinical Isolate Carrying a Plasmid-Mediated blaIMI-6 Gene (2023) (0)
«PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains inhibits lytic phage» (2021) (0)
Ertapenem for treatment of non-severe bacteremic urinary-tract infections due to ESBL-producing Enterobacterales in kidney transplant recipients: a propensity score and DOOR-based analysis. (2021) (0)
Computational Modeling and Design of New Inhibitors of Carbapenemases: A Discussion from the EPIC Alliance Network (2022) (0)
Evaluation of Vitek-MS™ and Microflex LT™ commercial systems for identification of Acinetobacter calcoaceticus–baumannii complex (2021) (0)
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae. (2023) (0)
Tracking a transcriptional host immune response of experimental Listeria monocytogenes infection using an ex-vivo nervous system model (2011) (0)
Community-acquired bacteremia by Klebsiella pneumoniae producing KPC-3 and resistant to ceftazidime/avibactam. (2022) (0)
Urinary tract infection caused by quinolone-resistantCampylobacter coli (1994) (0)
Proteomic Study of the Interactions between Phages and the Bacterial Host Klebsiella pneumoniae (2023) (0)
[Scientific publications and their influence in specialty teaching]. (2010) (0)
Comparison of two multiplexed PCR assays for respiratory virus detection in ICU patients: FilmArray® respiratory panel and Allplex™ respiratory full panel (2016) (0)
P881 Altered outer membrane protein profiles of Pseudomonas aeruginosa highly susceptible to the effiux pump inhibitor Phe-Arg-β-naphthylamide (2007) (0)
P1426 Microbiological aspects of a Streptococcus pyogenes outbreak causing invasive disease in children attending a day care centre in Cantabria, Spain (2007) (0)
[Ceftaroline breakpoints]. (2014) (0)
Non-molecular detection of carbapenemases in Enterobacteriaceae clinical isolates (2016) (0)
Author Correction: Human neutrophils phagocytose and kill Acinetobacter baumannii and A. pittii (2017) (0)
Erratum to: Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain (2012) (0)
Impact of a Carbapenem Stewardship Programme on the Incidence of Carbapenem-Resistant Gram-Negative Bacilli: An Interrupted Time-Series Analysis (2021) (0)
[Identification of clinically relevant fungi using molecular techniques]. (2011) (0)
Comparison of rapid drug susceptibility tests for Mycobacterium tuberculosis clinical isolates (2010) (0)
Monitoring of BK and JC polyomavirus viruria and viremia in hematopoietic stem cell transplant (HSCT) and renal transplant (RT) recipients (2016) (0)
Prognostic Significance of the Relative Load of KPC-Producing Klebsiella pneumoniae within the Intestinal Microbiota in a Prospective Cohort of Colonized Patients (2022) (0)
R2213 Comparison of different culture media and growth condi-tions for the recognition of Arcanobacterium haemolyticum (2007) (0)
Real-life use of cefiderocol for salvage therapy of severe infections due to carbapenem-resistant Gram-negative bacteria. (2023) (0)
P887 Linezolid resistance in clinical isolates of Staphylococcus haemolyticus (2007) (0)
Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain (2012) (0)
Edinburgh Research Explorer Identification of Atypical Rhodococcus-Like Clinical Isolates as Dietzia spp. by 16S rRNA Gene Sequencing (2010) (0)
Combined U se of the Ab105-2фΔCI L ytic M utant 2 P hage and D ifferent A ntibiotics in C linical I solates of 3 M ultiresistant Acinetobacter Baumannii 4 (2019) (0)
Characterization of group A beta-haemolytic streptococcus with mucoid phenotype isolated in a tertiary hospital. (2021) (0)
P828 Activity of daptomycin against coryneform bacteria isolated from clinical samples (2007) (0)
Author Correction: Genomic surveillance of enterovirus associated with aseptic meningitis cases in southern Spain, 2015–2018 (2021) (0)
Strains in Spain aeruginosa Pseudomonas and Enterobacteriaceae Testing with a Well-Defined Collection of-Lactam Susceptibility β Quality Control for (2003) (0)
Molecular characterization of multiresistant Escherichia coli producing or not extended-spectrum β-lactamases (2013) (0)
Occurrence of Corynebacterium striatum as an emerging antibiotic-resistant nosocomial pathogen in a Tunisian hospital (2017) (0)
Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study. (2022) (0)
Poster Sessions (1998) (0)
Klebsiella pneumoniae AcrAB Efﬂux Pump Contributes to Antimicrobial Resistance and Virulence (cid:1) (2009) (0)
Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports. (2022) (0)
Staphylococcus xylosus from a patient with cardiac and hepatic transplants (1988) (0)
[Streptococcus agalactiae: antimicrobial sensitivity and macrolide-resistant genotypes in genital specimens from pregnant patients in Cantabria]. (2005) (0)
Activities of Gemiﬂoxacin and Five Other Antimicrobial Agents against Listeria monocytogenes and Coryneform Bacteria Isolated from Clinical Samples (2001) (0)
[False sensitivity of Enterococcus faecium to amoxicillin-clavulanic acid with the MicroScan system]. (1995) (0)
Molecular identification of fungi of clinical relevance (2010) (0)
[The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem]. (2001) (0)
First report of carbapenem resistance in Klebsiella pneumoniae due to porin loss from Croatia (2011) (0)
Biofilm formation by multidrug resistant Enterobacteriaceae strains isolated from solid organ transplant recipients (2019) (0)
Title : Isolation of VIM-2-producing Pseudomonas monteilii clinical strains Disseminated 1 in a Tertiary Hospital in Northern Spain . (2014) (0)
[Opsonin requirements for phagocytosis of Enterococcus spp. by human polymorphonuclear leukocytes]. (1998) (0)
Molecular analysis of the interactions between phages and the bacterial host Klebsiella pneumoniae (2022) (0)
Characterization of group A beta-haemolytic streptococcus with mucoid phenotype isolated in a tertiary hospital. (2022) (0)
Case reportBacteremia caused by Leuconostoc Spp. (1992) (0)
From CLSI to EUCAST, a necessary step in Spanish laboratories (2020) (0)
)-Ib-cr ' Containing qnrB, qnrS, and/or aac(6 Susceptibility Testing of Enterobacteria Evaluation of Three Automated Systems for (2014) (0)
panish Consensus on the Prevention and Treatment of Pseudomonas eruginosa Bronchial Infections in Cystic Fibrosis Patients (2018) (0)
First report of reduced carbapenem susceptibility in Klebsiella pneumoniae from Croatia- In vivo development of resistance (2010) (0)
Increased Antimicrobial Resistance in a Novel CMY-54 AmpC-Type Enzyme with a GluLeu217-218 Insertion in the Ω-Loop. (2018) (0)
carbapenems in Acinetobacter pittii from Spain (2014) (0)
[Production of slime by Staphylococcus epidermidis]. (1991) (0)
[Multiresistant pathogens in cystic fibrosis]. (2002) (0)
Four Main Virotypes among Extended-Spectrum- (cid:1) -Lactamase-Producing Isolates of Escherichia coli O25b:H4-B2-ST131: Bacterial, Epidemiological, and Clinical Characteristics A total of 1,021 extended-spectrum- (cid:1) -lactamase-producing (2013) (0)
[Report from the editorial board]. (2003) (0)
P1018 Relationship between clonal variability, phylogenetic groups and multiresistance amoung extraintestinal isolates of Escherichia coli lacking extended-spectrum β-lactamases (2007) (0)
[Duplicate publication: Infectious endocarditis by Ochrobactrum anthropi on immunocompetent patient]. (2005) (0)
Justification for 24/7 clinical microbiology services. (2022) (0)
R2201 Enterobacter aerogenes strains misidentified as Klebsiella pneumoniae and correct identification by sequencing of the QRDR region of the gyrA gene (2007) (0)
P866 Mutators are not responsible for the association between β-lactam and quinolone resistance in Escherichia coli with AmpC hyperproduction phenotype (2007) (0)
Effect of clavulanic acid and beta-lactamase on phagocytosis ofStaphylococcus aureus (1990) (0)

This paper list is powered by the following services:

Luis Martı́nez-martı́nez's Academic­Influence.com Rankings

Luis Martı́nez-martı́nez's Degrees

Similar Degrees You Can Earn

Why Is Luis Martı́nez-martı́nez Influential?

Luis Martı́nez-martı́nez's Published Works

Published Works

Luis Martı́nez-martı́nez's AcademicInfluence.com Rankings